Related references
Note: Only part of the references are listed.A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Mark G. Swain et al.
GASTROENTEROLOGY (2010)
Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis
Savino Bruno et al.
HEPATOLOGY (2010)
Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study
Savino Bruno et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b A Randomized Trial
Donald M. Jensen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
Clinical, Virologic, Histologic, and Biochemical Outcomes After Successful HCV Therapy: A 5-Year Follow-up of 150 Patients
Sarah L. George et al.
HEPATOLOGY (2009)
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis
Tommaso Stroffolini et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C
Vincent Mallet et al.
ANNALS OF INTERNAL MEDICINE (2008)
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
Bart J. Veldt et al.
ANNALS OF INTERNAL MEDICINE (2007)
Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C
Atsushi Tanaka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection
Yasuji Arase et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study
Kazuki Ikeda et al.
ANNALS OF INTERNAL MEDICINE (2007)
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis
Ruben Raphael Plentz et al.
HEPATOLOGY (2007)
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients
S. Kobayashi et al.
LIVER INTERNATIONAL (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients
Angelo Sangiovanni et al.
HEPATOLOGY (2006)
Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus
A Tamori et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
M Ikeda et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2005)
Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy
Y Iwasaki et al.
LIVER INTERNATIONAL (2004)
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
T Pollicino et al.
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy
A Makiyama et al.
CANCER (2004)
Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications
L Benvegnù et al.
GUT (2004)
Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
K Hino et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Molecular pathogenesis of human hepatocellular carcinoma
SS Thorgeirsson et al.
NATURE GENETICS (2002)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard et al.
JOURNAL OF HEPATOLOGY (2001)
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis:: an evidence-based approach
C Cammà et al.
JOURNAL OF HEPATOLOGY (2001)
Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death
F Degos et al.
GUT (2000)
Share Paper
